CareToLive RSS

Subscribe to the CareToLive RSS feed for up to date news and developments surrounding the legal battle against the FDA and more. (RSS feed reader required)
Spread The Word

Please help spread the word about CareToLive. Any of the information found on this website can be distributed and shared freely. We only ask that you provide a link back to this website if you publish our content.
Donations

CareToLive is a not for profit corporation; however, donations are NOT tax exempt.
« New FDA Commissioner - Change or More of the Same
THE NEXT FDA COMMISSIONER »

Care To Live Member / Prostate Cancer Patient, Ted Girgus, Tonight on Radio

December 10th, 2008 | Posted by Rory Kearney
Share This

Tonight Ted Girgus to discuss Prostate Cancer and Provenge on Andrew Schorr’s Patient Power 9 PM EDT, 6 PM PDT

http://www.patientpower.info/webcastdetails.asp?dateid=
12/10/2008&webcastid=SCCA121008

If you have any questions you would like answered please
Email questions to: questions@patientpower.info

and help spread the word

Video of Ted Girgus who has late stage prostate cancer and is desperately waiting for the past several years for Provenge approval.

http://youtube.com/watch?v=6Q0uQAL_YDA


12/10/2008

6:00 - 7:00 pm PST

9PM EDT
Navigating Dilemmas Posed by Prostate Cancer Treatment Options
Live from (6:00 - 7:00 pm PST) Pacific. Check back for a link to the live program.

Treatment for localized prostate cancer carries with it not only issues of cancer control, but significant impact on health related quality of life. Measurement of cancer control and HRQOL outcomes is yet to be fully explored by the medical community. In this webcast, join Dr. Bruce Dalkin as we focus on how to measure cancer control in an optimal fashion and .

Guests:
Bruce Dalkin, M.D., Urologic Oncologist, Seattle Cancer Care Alliance
Ted Girgus, Prostate Cancer Patient
Peter Frishauf, Founder of Medscape

How to participate

Email questions to: questions@patientpower.info

Popularity: 25%

Tags: , , , , , , , , , , ,

This entry was posted on Wednesday, December 10th, 2008 at 5:31 pm and is filed under The Cause, The Dysfunctional FDA. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

2 Responses to “Care To Live Member / Prostate Cancer Patient, Ted Girgus, Tonight on Radio”

  1. 1.
    Care To Live Member / Prostate Cancer Patient, Ted Girgus, Tonight on Radio · Prostate Cancer
    Says:

    December 10th, 2008 at 7:15 pm

    […] Miscellanea Agnostica wrote an interesting post today onHere’s a quick excerpt Tonight Ted Girgus to discuss Prostate Cancer and Provenge on Andrew Schorr’s Patient Power 9 PM EDT, 6 PM PDT http://www.patientpower.info/webcastdetails.asp?dateid= 12/10/2008&webcastid=SCCA121008 If you have any questions you would like answered please Email questions to: questions@patientpower.info and help spread the word Video of Ted Girgus who has late stage prostate cancer and is desperately waiting for the past several years for Provenge approval. http://youtube.com/watch? […]

     Add karma Subtract karma  +1
  2. 2.
    seattle cancer care alliance website | Digg hot tags
    Says:

    December 11th, 2008 at 4:41 am

    […] Vote Care To Live Member Ted Girgus Prostate Cancer Patient Tonight on … […]

     Add karma Subtract karma  +1

Post a Comment...

LATEST POSTS

MOST POPULAR

CATEGORIES

WHATS GOING ON

This Is An Emergency!

We rallied outside the FDA building in Rockville, Maryland on September 18th. Now there are buses riding around Rockville and Washington, D.C., further protesting the shenanigans that took place inside the FDA building, as well as outside.

The FDA has gotten caught up with Wall Street. While it is supposed to be busy with evaluating food and drugs, its employees just can't keep their eyes off the money. So that is how decisions are being made these days.
WE'LL BE BACK

These people traveled from all across the country to protest outside the FDA Building in Rockville, Maryland. The FDA has stopped a safe and effective treatment from getting to men who need it now. The treatment is called Provenge and it treats men who have late stage prostate cancer.

The FDA appointed a panel of experts to help it decide on the safety and efficacy of Provenge. That panel voted 17-0 that Provenge was safe. And it voted 13-4 that Provenge showed substantial evidence it worked. And yet the FDA delayed it. Now it could be a year, a year and a half or it could be three years. It could be forever.

These people will keeping coming back to Rockville and they hope others will join them until the courts, the FDA, Congress or somebody does something about this travesty.